Gonadotropin-releasing hormone (GnRH)-I and GnRH-II induce cell growth inhibition in human endometrial cancer cells: Involvement of integrin beta3 and focal adhesion kinase
<p>Abstract</p> <p>Endometrial carcinoma is the most common neoplasm of the female genital tract, accounting for nearly one half of all gynecologic cancers in the Western world. Although intensive research on pathological phenomena of endometrial cancer is currently going on, but e...
Main Authors: | MacCalman Colin D, Choi Kyung-Chul, Park Dong, Leung Peter CK |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-08-01
|
Series: | Reproductive Biology and Endocrinology |
Online Access: | http://www.rbej.com/content/7/1/81 |
Similar Items
-
Gonadotropin-Releasing Hormone (GnRH) Receptor Structure and GnRH Binding
by: Colleen A. Flanagan, et al.
Published: (2017-10-01) -
Transciptional regulation of human gonadotropin-releasing hormone (GnRH) and GnRH receptor genes
by: Cheng, Chi Keung
Published: (2009) -
The Role of Gonadotropin-Releasing Hormone (GnRH) in Endometrial Cancer
by: Günter Emons, et al.
Published: (2021-02-01) -
Studies on ovarian GnRH-R and GnRH mRNA, and the direct effects of GnRH on ovarian function in the bovine
by: Ramakrishnappa, Nagaraja
Published: (2009) -
Comparison of GnRH Agonist, GnRH Antagonist, and GnRH Antagonist Mild Protocol of Controlled Ovarian Hyperstimulation in Good Prognosis Patients
by: Martin Stimpfel, et al.
Published: (2015-01-01)